(90%),

Shemaroo Contentino Transforms Inflight Entertainment with 90% Dominance of the Premium Indian Content Market

MUMBAI, India, Nov. 28, 2024 /PRNewswire/ -- The aviation industry is experiencing unprecedented heights, driven by expansive and rapidly growing national…

3 days ago

Shemaroo Contentino Transforms Inflight Entertainment with 90% Dominance of the Premium Indian Content Market

MUMBAI, India, Nov. 28, 2024 /PRNewswire/ -- The aviation industry is experiencing unprecedented heights, driven by expansive and rapidly growing national…

4 days ago

Shemaroo Contentino Transforms Inflight Entertainment with 90% Dominance of the Premium Indian Content Market

MUMBAI, India, Nov. 28, 2024 /PRNewswire/ -- The aviation industry is experiencing unprecedented heights, driven by expansive and rapidly growing national…

5 days ago

Shemaroo Contentino Transforms Inflight Entertainment with 90% Dominance of the Premium Indian Content Market

MUMBAI, India, Nov. 28, 2024 /PRNewswire/ -- The aviation industry is experiencing unprecedented heights, driven by expansive and rapidly growing national…

5 days ago

Shemaroo Contentino Transforms Inflight Entertainment with 90% Dominance of the Premium Indian Content Market

MUMBAI, India, Nov. 28, 2024 /PRNewswire/ -- The aviation industry is experiencing unprecedented heights, driven by expansive and rapidly growing national…

6 days ago

Shemaroo Contentino Transforms Inflight Entertainment with 90% Dominance of the Premium Indian Content Market

MUMBAI, India, Nov. 28, 2024 /PRNewswire/ -- The aviation industry is experiencing unprecedented heights, driven by expansive and rapidly growing national…

6 days ago

Attruby (acoramidis), a Near Complete TTR Stabilizer (90%), approved by FDA to Reduce Cardiovascular Death and Cardiovascular-related Hospitalization in ATTR-CM Patients

- Attruby is the first and only approved product with aspecifying near-complete stabilization of TTR. Attruby has been…

1 week ago

Attruby (acoramidis), a Near Complete TTR Stabilizer (90%), approved by FDA to Reduce Cardiovascular Death and Cardiovascular-related Hospitalization in ATTR-CM Patients

- Attruby is the first and only approved product with aspecifying near-complete stabilization of TTR. Attruby has been…

2 weeks ago